Bure Equity AB Stock price

Equities

BURE

SE0000195810

Investment Holding Companies

Market Closed - Nasdaq Stockholm 07:59:54 2024-03-28 am EDT 5-day change 1st Jan Change
342.8 SEK +1.30% Intraday chart for Bure Equity AB +1.54% +19.94%
Sales 2021 6.43B 601M Sales 2022 -9.17B -857M Capitalization 18.27B 1.71B
Net income 2021 6.35B 594M Net income 2022 -9.24B -864M EV / Sales 2021 4.98 x
Net cash position 2021 455M 42.52M Net cash position 2022 529M 49.43M EV / Sales 2022 -1.93 x
P/E ratio 2021
5.12 x
P/E ratio 2022
-1.98 x
Employees 10
Yield 2021
0.51%
Yield 2022
0.91%
Free-Float 70.71%
More Fundamentals * Assessed data
Dynamic Chart
Bure Equity AB Proposes Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024 CI
Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Bure Equity AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
An Unknown buyer acquired 3.8% stake in Mycronic AB (OM:MYCR) from Bure Equity AB (OM:BURE) for SEK 870 million. CI
Bure Equity AB Announces Appointment of Nominating Committee CI
Yubico AB completed the acquisition of ACQ Bure AB (OM:ACQ SPAC) from a group of shareholders in a reverse merger transaction. CI
Bure Equity AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vitrolife AB (publ) : A pioneer in in vitro fertilization Our Logo
Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bure Equity AB Approves Ordinary Cash Dividend, Payable on 10 May 2023 CI
Yubico AB agreed to acquire ACQ Bure AB (OM:ACQ SPAC) from a group of shareholders for SEK 8.2 billion in a reverse merger transaction. CI
Bure Equity AB Proposes Dividend for the Financial Year 2022, Payable on 10 May 2023 CI
Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day+1.30%
1 week+1.54%
Current month+3.32%
1 month+7.39%
3 months+19.44%
6 months+64.49%
Current year+19.94%
More quotes
1 week
331.00
Extreme 331
343.80
1 month
321.40
Extreme 321.4
346.00
Current year
272.40
Extreme 272.4
346.00
1 year
202.20
Extreme 202.2
346.00
3 years
171.30
Extreme 171.3
489.20
5 years
126.40
Extreme 126.4
489.20
10 years
26.40
Extreme 26.4
489.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 98-12-31
Director of Finance/CFO 56 13-09-30
Chairman 60 98-12-31
Members of the board TitleAgeSince
Director/Board Member 66 19-04-30
Chairman 60 98-12-31
Director/Board Member 69 16-05-09
More insiders
Date Price Change Volume
24-03-28 342.8 +1.30% 20,586
24-03-27 338.4 +1.87% 101,832
24-03-26 332.2 -1.48% 48,392
24-03-25 337.2 -0.77% 39,986
24-03-22 339.8 +0.12% 34,872

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT

More quotes
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock
  2. Equities
  3. Stock Bure Equity AB - Nasdaq Stockholm